Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.1000
-0.0150 (-13.04%)
Feb 26, 2026, 3:54 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 22.71 million as of February 25, 2026. Its market cap has decreased by -84.19% in one year.
Market Cap
22.71M
Enterprise Value
-7.79M
Revenue
19.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 22.71M, a decrease of -35.79%. That is a compound annual growth rate of -3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 26.12M | -54.00% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 894.51M |
| Healius | 497.40M |
| Australian Clinical Labs | 420.61M |
| Monash IVF Group | 284.43M |
| Rhythm Biosciences | 67.12M |
| Cryosite | 58.57M |
| Microba Life Sciences | 51.15M |
| INOVIQ | 47.16M |